Barinthus Biotherapeutics plc
BRNS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $74 | $86 | $99 | $111 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $5 | $4 | $13 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $13 | $9 | $7 | $2 |
| Total Curr. Assets | $87 | $100 | $110 | $126 |
| Property Plant & Equip (Net) | $7 | $8 | $10 | $12 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $15 | $20 | $21 | $22 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $1 |
| Total NC Assets | $22 | $29 | $32 | $35 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $109 | $130 | $142 | $160 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $2 |
| Short-Term Debt | $2 | $2 | $2 | $2 |
| Tax Payable | $0 | $0 | $0 | $2 |
| Deferred Revenue | $0 | $2 | $1 | $2 |
| Other Curr. Liab. | $8 | $7 | $7 | $7 |
| Total Curr. Liab. | $11 | $13 | $12 | $16 |
| LT Debt | $10 | $10 | $10 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4 | $4 | $4 | $4 |
| Total NC Liab. | $14 | $14 | $14 | $15 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $12 | $12 | $12 | $12 |
| Total Liabilities | $25 | $27 | $26 | $30 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$293 | -$278 | -$257 | -$238 |
| AOCI | -$16 | -$13 | -$21 | -$26 |
| Other Equity | $393 | $394 | $394 | $394 |
| Total Equity | $84 | $102 | $115 | $130 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $109 | $130 | $142 | $160 |
| Net Debt | -$63 | -$74 | -$87 | -$99 |